C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 209/30 (2006.01) A61K 31/404 (2006.01) A61K 31/427 (2006.01) A61K 31/4439 (2006.01) A61K 31/4709 (2006.01) C07D 401/02 (2006.01) C07D 417/10 (2006.01) C12N 9/02 (2006.01) C12N 9/99 (2006.01)
Patent
CA 2628467
Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.
L'invention concerne des composés et des compositions pharmaceutiques contenant de tels composés, qui permettent de moduler l'activité de la protéine d'activation de la 5-lipoxygénase (FLAP). Cette invention a aussi pour objet des méthodes d'utilisation de modulateurs de cette protéine d'activation de la 5-lipoxygénase (FLAP), seuls et en combinaison avec d'autres composés, dans le traitement de troubles ou de maladies respiratoires, cardio-vasculaires et dépendants de la leukotriène ou médiés par la leukotriène.
Arruda Jeannie M.
Evans Jillian F.
Hutchinson John H.
Li Yiwei
Moran Mark
Amira Pharmaceuticals Inc.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
5-lipoxygenase-activating protein (flap) inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-lipoxygenase-activating protein (flap) inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-lipoxygenase-activating protein (flap) inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2023944